// App-Quantinova.ai

S3024 2015 AHA : Clinically Feasible Electronic Health Record Tool for Stratification of 1- to 3-year Post-myocardial Infarction Risk of Cardiovascular Events: The Intermountain Acute Coronary Syndromes Risk Scores

Researchers

Presenter

  • Joseph B Muhlestein

Principal Investigators

  • Durgesh Bhandary

  • Greta L Hoetzer

  • Naeem D. Khan

  • Tami L Bair

  • Donald L Lappe

Medical Centers

  • Intermountain Medical Ctr, Univ of Utah, Salt Lake City, UT

  • Intermtn Medcl Ctr, Salt Lake City, UT

Locations

  • United States

Companies

  • AstraZeneca plc

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Post-myocardial infarction

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • B-type natriuretic peptide

  • Hemoglobin A1c

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved